These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 914731)

  • 81. The clinical roles of pulmonary function testing.
    Andrews JL
    Med Clin North Am; 1979 Mar; 63(2):355-77. PubMed ID: 439960
    [No Abstract]   [Full Text] [Related]  

  • 82. The use of maximum expiratory flow-volume curves on air and He/O2 to assess peripheral pressure losses in the airways.
    Pedersen OF; Ingram RH
    Bull Eur Physiopathol Respir; 1987; 23(6):649-62. PubMed ID: 3331126
    [No Abstract]   [Full Text] [Related]  

  • 83. [Determination of maximal expiratory flow-volume curves of 815 normal children and adolescents in Chengdu].
    Huang GF; Li JH; Feng DH; Liu ZG; Lü GN; Peng GH; Feng ZY; Ye X; Zhang HY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Dec; 16(4):318-21. PubMed ID: 3837391
    [No Abstract]   [Full Text] [Related]  

  • 84. Effects of an inhaled bronchodilator on gas distribution and over-all ventilatory efficiency in patients with chronic obstructive pulmonary disease.
    Cutillo A; Perondi R; Turiel M; Monti S
    Am J Med; 1976 Jul; 61(1):74-84. PubMed ID: 937373
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Expiratory flow limitation.
    Hyatt RE
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Jul; 55(1 Pt 1):1-7. PubMed ID: 6350246
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine.
    Ahrens RC; Bonham AC; Maxwell GA; Weinberger MM
    Am Rev Respir Dis; 1984 Jun; 129(6):903-6. PubMed ID: 6375489
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of onset of bronchodilating effect by interruption of the air flow method.
    Lulling J; Delwiche JP; Prignot J
    Eur J Respir Dis; 1980 Apr; 61(2):108-12. PubMed ID: 7002572
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Functional consequences of lung volume reduction surgery for COPD.
    Wagner PD
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1017-9. PubMed ID: 9769253
    [No Abstract]   [Full Text] [Related]  

  • 89. [The density-dependence of maximal respiratory flow as an exploratory test of the small airways].
    Bonsignore G; Rizzo A; Bellia V; Ferrara G; Sciarabba G
    Recenti Prog Med; 1977 Apr; 62(4):389-405. PubMed ID: 577615
    [No Abstract]   [Full Text] [Related]  

  • 90. [Descent gradient of maximal expiratory flow-volume curve and uneven distribution of ventilation].
    Uzawa T; Tamura S; Tsuzuki N; Kumazaki S; Inoue T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Mar; 23(3):355-62. PubMed ID: 4032877
    [No Abstract]   [Full Text] [Related]  

  • 91. Volume of isoflow in the detection of airway obstruction and abnormalities of lung elasticity in man.
    Zapletal A; Samanek M
    Bull Eur Physiopathol Respir; 1979; 14(3):265-77. PubMed ID: 476324
    [No Abstract]   [Full Text] [Related]  

  • 92. Effects of lung volume and thoracic gas compression on maximal and partial flow-volume curves.
    Pellegrino R; Confessore P; Bianco A; Brusasco V
    Eur Respir J; 1996 Oct; 9(10):2168-73. PubMed ID: 8902484
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Forced expiratory test, maximum ventilation, resistance and flow-volume curve--possibilities of a comprehensive characterization of airway obstruction and respiratory reserve].
    Seidel A
    Pneumologie; 1998 Aug; 52(8):437-8. PubMed ID: 9774868
    [No Abstract]   [Full Text] [Related]  

  • 94. Dose-related dilatation of airways after inhalation of metaproterenol sulfate.
    Popa VT; Werner P
    Chest; 1976 Aug; 70(2):205-11. PubMed ID: 947685
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
    Würtemberger G; Weil R; Schulte-Mönting J; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608
    [No Abstract]   [Full Text] [Related]  

  • 96. Clinical Utility of Additional Measurement of Total Lung Capacity in Diagnosing Obstructive Lung Disease in Subjects With Restrictive Pattern of Spirometry.
    Lee H; Chang B; Kim K; Song WJ; Chon HR; Kang HK; Kim JS; Jeong BH; Oh YM; Koh WJ; Park HY
    Respir Care; 2016 Apr; 61(4):475-82. PubMed ID: 26884447
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Significance of the study of the critical transmural pressure in analysis of the factors limiting maximal expiratory flow rate].
    Marsico SA; Tranfa CM; Cantatore D; Illiano A; Sanduzzi A; Lopa M
    Arch Monaldi; 1980; 35(3):97-104. PubMed ID: 7316666
    [No Abstract]   [Full Text] [Related]  

  • 98. Reversibility of airway obstruction in relation to prognosis in chronic obstructive pulmonary disease.
    Kawakami Y; Kishi F; Dohsaka K; Nishiura Y; Suzuki A
    Chest; 1988 Jan; 93(1):49-53. PubMed ID: 3335167
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Regional impairment of mucociliary clearance in chronic obstructive pulmonary disease.
    Smaldone GC; Foster WM; O'Riordan TG; Messina MS; Perry RJ; Langenback EG
    Chest; 1993 May; 103(5):1390-6. PubMed ID: 8486016
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Physiologic differentiation of upper and lower airway obstruction.
    Davidson FF; Burke GW
    Ann Otol Rhinol Laryngol; 1977; 86(5 Pt 1):630-2. PubMed ID: 911142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.